Your browser doesn't support javascript.
loading
The genetics of nodal marginal zone lymphoma.
Spina, Valeria; Khiabanian, Hossein; Messina, Monica; Monti, Sara; Cascione, Luciano; Bruscaggin, Alessio; Spaccarotella, Elisa; Holmes, Antony B; Arcaini, Luca; Lucioni, Marco; Tabbò, Fabrizio; Zairis, Sakellarios; Diop, Fary; Cerri, Michaela; Chiaretti, Sabina; Marasca, Roberto; Ponzoni, Maurilio; Deaglio, Silvia; Ramponi, Antonio; Tiacci, Enrico; Pasqualucci, Laura; Paulli, Marco; Falini, Brunangelo; Inghirami, Giorgio; Bertoni, Francesco; Foà, Robin; Rabadan, Raul; Gaidano, Gianluca; Rossi, Davide.
Afiliação
  • Spina V; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Khiabanian H; Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;
  • Messina M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Monti S; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Cascione L; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
  • Bruscaggin A; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Spaccarotella E; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Holmes AB; Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY;
  • Arcaini L; Department of Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy;
  • Lucioni M; Division of Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;
  • Tabbò F; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;
  • Zairis S; Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;
  • Diop F; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Cerri M; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Chiaretti S; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Marasca R; Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;
  • Ponzoni M; Ateneo Vita-Salute and Unit of Lymphoid Malignancies, San Raffaele H. Scientific Institute, Milan, Italy;
  • Deaglio S; Department of Medical Sciences, University of Torino and Immunogenetics Unit, Human Genetics Foundation, Torino, Italy;
  • Ramponi A; Division of Pathology, Department of Health Sciences, Amedeo Avogadro University of Eastern Piedmont and Maggiore Hospital, Novara, Italy;
  • Tiacci E; Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy;
  • Pasqualucci L; Institute for Cancer Genetics and the Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY;
  • Paulli M; Division of Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;
  • Falini B; Institute of Hematology, Ospedale S. Maria della Misericordia, University of Perugia, Perugia, Italy;
  • Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY; Department of Molecular Biotechnology and Health Science and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy; and Department of Pathology, NYU Cancer Center, New Yo
  • Bertoni F; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
  • Foà R; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy;
  • Rabadan R; Department of Biomedical Informatics and Systems Biology, Columbia University, New York, NY;
  • Gaidano G; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy;
  • Rossi D; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Institute of Oncology Research and Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
Blood ; 128(10): 1362-73, 2016 09 08.
Article em En | MEDLINE | ID: mdl-27335277
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Biomarcadores Tumorais / Linfoma de Zona Marginal Tipo Células B / Receptor Notch2 / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores / Exoma / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esplênicas / Biomarcadores Tumorais / Linfoma de Zona Marginal Tipo Células B / Receptor Notch2 / Proteínas Tirosina Fosfatases Classe 2 Semelhantes a Receptores / Exoma / Mutação Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article